Bostonscientific stories:
J&J: New 'Nevo' Stent Outperforms Rival Device In Trial
May 19th, 2009 - CNNMoney
A new drug-releasing heart stent Johnson & Johnson (JNJ) hopes will rejuvenateits standing in the $4 billion market for the tiny devices outperformed a BostonScientific Corp...
Boston Scientific Stents Less Effective Than Others in Studies
Mar 30th, 2009 - Bloomberg
March 30 (Bloomberg) -- Heart stents made by BostonScientific Corp., the world’s biggest seller of the artery-clearing devices, were less effective in studies than those fromAbbott Laboratories...



